The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease

scientific article published in March 2008

The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/INF.0B013E31815AC585
P698PubMed publication ID18277934

P50authorKate O'BrienQ6376501
Mathuram SantoshamQ56425974
Ruth A KarronQ92344448
P2093author name stringRaymond Reid
Bhagvanji Thumar
Jana Shaw
Angelia Eick
P433issue3
P921main subjectantibodyQ79460
P304page(s)207-212
P577publication date2008-03-01
P1433published inPediatric Infectious Disease JournalQ15756717
P1476titleThe role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease
P478volume27

Reverse relations

cites work (P2860)
Q37578458A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
Q37135395Antibody response to respiratory syncytial virus infection in children <18 months old
Q35915613Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study
Q36263882Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age
Q40959795Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells
Q38162418Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity
Q64060972Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Q39256577Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.
Q36440236Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea
Q38631747In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.
Q34360625Inflammatory responses to acute pneumovirus infection in neonatal mice
Q41875572Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort
Q101137473Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity
Q89884849Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation
Q38628928New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.
Q59358180Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy
Q42652733Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV.
Q56894869Progress in respiratory virus vaccine development
Q36665660Progress toward a Respiratory Syncytial Virus Vaccine
Q96136323Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics
Q35102554Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh
Q59351084Respiratory syncytial virus vaccine: where are we now and what comes next?
Q35761061Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
Q38819027Strategies to develop vaccines of pediatric interest
Q38140040Translational sciences approach to RSV vaccine development
Q52652828Virus-specific aNtibody, Viral Load and Disease Severity in Respiratory Syncytial Virus Infection.

Search more.